Who
Eric K. Rowinsky
Director
Company insider
Files Form 4 as: Director, Biogen; Director, Verastem; Director, Fortress Biotech; Director, Navidea Biopharmaceuticals; Director, Dnib Unwind; Chief Medical Officer, Stemline Therapeutics; Director, Savara; SVP, Chief Medical Officer, Imclone Systems.
In numbers
- Trades disclosed
- 141
- Buys
- 4
- Sells
- 15
- Bought
- $157K
- Sold
- $13.4M
- Companies
- 8
- Companies where not an officer
- 6
- First trade
- 18 Jan 2006
- Last trade
- 9 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 11 Jun 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —1,505 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —1,505 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —2,370 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | VSTM Verastemoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | —8,333 at $0.00 | filing |
| 21 Jun 2024filed 25 Jun 2024 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —1,340 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | VSTM Verastemoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | —8,333 at $0.00 | filing |
| 11 Mar 2024filed 13 Mar 2024 | VSTM Verastemoption or derivative · Biotechnology | SEC FORM 4 Code D | —4,166 | filing |
| 11 Mar 2024filed 13 Mar 2024 | VSTM Verastemoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,157 | filing |
| 11 Mar 2024filed 13 Mar 2024 | VSTM Verastemoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,083 | filing |
| 11 Mar 2024filed 13 Mar 2024 | VSTM Verastemoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,083 | filing |
| 11 Mar 2024filed 13 Mar 2024 | VSTM Verastemoption or derivative · Biotechnology | SEC FORM 4 Code D | —2,083 | filing |
| 11 Mar 2024filed 13 Mar 2024 | VSTM Verastemoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,572 | filing |
| 15 Feb 2024filed 20 Feb 2024 | BIIB BiogenBiotechnology | SEC FORM 4 Bought | $101K455 at $222.54 | filing |
| 1 Jan 2024filed 3 Jan 2024 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —6,666 at $0.00 | filing |
| 26 Jun 2023filed 28 Jun 2023 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —960 at $0.00 | filing |
| 15 May 2023filed 16 May 2023 | VSTM Verastemoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
News
Head to Head Analysis: Fortress Biotech (NASDAQ:FBIO) versus 60 Degrees Pharmaceuticals (NASDAQ:SXTP)FBIO · tickerreport.com · 17 Oct 2026Verastem (NASDAQ:VSTM) Stock Price Target Raised at MizuhoVSTM · tickerreport.com · 16 Oct 2026Verastem (NASDAQ:VSTM) Shares Gap Up – Time to Buy?VSTM · tickerreport.com · 14 Oct 2026Biogen (NASDAQ:BIIB) Hits New 52-Week High Following Analyst UpgradeBIIB · dailypolitical.com · 14 Oct 2026Verastem (NASDAQ:VSTM) Stock Falls 7% – Here's What HappenedVSTM · themarketsdaily.com · 13 Oct 2026Biogen (BIIB) vs Amgen (AMGN) and Gilead (GILD): Which Big Pharma Stock is a Better Buy?BIIB · insidermonkey.com · 13 Oct 2026Critical Survey: Fortress Biotech (NASDAQ:FBIO) vs. 60 Degrees Pharmaceuticals (NASDAQ:SXTP)FBIO · tickerreport.com · 11 Oct 2026Biogen (NASDAQ:BIIB) Stock Price Target Cut by Royal Bank Of CanadaBIIB · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Eric K. Rowinsky; 9 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.